- Correction
- Open access
- Published:
Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review
Pediatric Rheumatology volume 20, Article number: 76 (2022)
Correction: Pediatr Rheumatol 20, 60 (2022)
https://doi.org/10.1186/s12969-022-00723-5
The original publication of this article [1] contained an incorrect author name. The incorrect and correct name are shown below. The original article has been updated.
Author name
-
The incorrect author name is: Naofumi Gima
-
The correct author name is: Masafumi Gima
Reference
Nishi K, et al. Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review. Pediatr Rheumatol. 2022;20:60. https://doi.org/10.1186/s12969-022-00723-5.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/. The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
About this article
Cite this article
Nishi, K., Ogura, M., Tamai, N. et al. Correction: Successful rituximab treatment for severe rapidly progressive interstitial lung disease with anti-MDA5 antibody-positive juvenile dermatomyositis: a case report and literature review. Pediatr Rheumatol 20, 76 (2022). https://doi.org/10.1186/s12969-022-00736-0
Published:
DOI: https://doi.org/10.1186/s12969-022-00736-0